Stay updated on Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page. The lapse-in-government-funding notice and the earlier Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:20:09.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH Clinical Center operating status was added, and the site version updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:11:37.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary display and several new meta fields (Results First Posted, Certification/Extension First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0). Removed older or estimated fields (Results First Posted (Estimated), Certification/Extension First Posted (Estimated), Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.3%
    Check dated 2026-01-28T03:30:49.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Minor revision history updated: added v3.3.4 and removed v3.3.3; no substantive changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:18:08.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added new trial locations: New Hampshire, Wisconsin, and Badalona, and updated the location sections accordingly. The HHS Vulnerability Disclosure link was removed, and the page revision was updated from v3.3.2 to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T08:11:12.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed on the page, replacing v3.3.1. This is a minor site update and does not alter study information.
    Difference
    0.0%
    Check dated 2025-12-01T16:29:45.000Z thumbnail image

Stay in the know with updates to Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.